These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28004988)

  • 1. Biosynthetic Grafts To Replace Infected Prosthetic Vascular Bypasses: A Single-Center Experience.
    Töpel I; Stigler T; Ayx I; Betz T; Uhl C; Steinbauer M
    Surg Infect (Larchmt); 2017; 18(2):202-205. PubMed ID: 28004988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of biosynthetic prosthesis (Omniflow II®) to replace infected infrainguinal prosthetic grafts--first results.
    Töpel I; Betz T; Uhl C; Wiesner M; Bröckner S; Steinbauer M
    Vasa; 2012 May; 41(3):215-20. PubMed ID: 22565623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
    Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
    J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of biosynthetic vascular graft for infrainguinal femoro-popliteal and femoro-distal revascularization.
    Socrate AM; Spampinato B; Zuccon G; Ferraris M; Costantini A; Piffaretti G
    J Cardiovasc Surg (Torino); 2021 Aug; 62(4):369-376. PubMed ID: 33829745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthetic vascular graft: a valuable alternative to traditional replacement materials for treatment of prosthetic aortic graft infection?
    Betz T; Neuwerth D; Steinbauer M; Uhl C; Pfister K; Töpel I
    Scand J Surg; 2019 Dec; 108(4):291-296. PubMed ID: 30520347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts.
    Neufang A; Dorweiler B; Espinola-Klein C; Savvidis S; Doemland M; Schotten S; Vahl CF
    J Vasc Surg; 2014 Dec; 60(6):1543-53. PubMed ID: 25238725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omniflow II biosynthetic grafts versus expanded polytetrafluoroethylene grafts for infrainguinal bypass surgery. A single-center retrospective analysis.
    van de Laar BC; van Heusden HC; Pasker-de Jong PC; van Weel V
    Vascular; 2022 Aug; 30(4):749-758. PubMed ID: 34210216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts.
    Faries PL; Logerfo FW; Arora S; Hook S; Pulling MC; Akbari CM; Campbell DR; Pomposelli FB
    J Vasc Surg; 2000 Dec; 32(6):1080-90. PubMed ID: 11107079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
    Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
    J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Graft, Limb and Mortality Outcomes from the Omniflow II Bio-Synthetic Graft.
    Evans W; Buchanan J; Goel R; Hardy S
    Ann Vasc Surg; 2022 Jan; 78():321-327. PubMed ID: 34464727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Omniflow® II prosthesis used for revascularization in the femoral tract both in infected and non-infected setting.
    Liesker DJ; Gareb B; Speijers MJ; VAN DER Vorst JR; Salemans PB; Tutein Nolthenius RP; Zeebregts CJ; Saleem BR
    J Cardiovasc Surg (Torino); 2023 Dec; 64(6):634-644. PubMed ID: 37306682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft.
    Pulli R; Dorigo W; Castelli P; Dorrucci V; Ferilli F; De Blasis G; Monaca V; Vecchiati E; Pratesi C;
    J Vasc Surg; 2010 May; 51(5):1167-1177.e1. PubMed ID: 20347549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Omniflow® II Biosynthetic Graft for the Treatment of Vascular Graft and Endograft Infections.
    Liesker DJ; Gareb B; Speijers MJ; van der Vorst JR; Salemans PB; Tutein Nolthenius RP; Zeebregts CJ; Saleem BR
    Ann Vasc Surg; 2023 Nov; 97():410-418. PubMed ID: 37244480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early results after peripheral vascular replacement with biosynthetic collagen prosthesis in cases of graft infection].
    Fellmer PT; Wiltberger G; Tautenhahn HM; Matia I; Krenzien F; Jonas S
    Zentralbl Chir; 2014 Oct; 139(5):546-51. PubMed ID: 23341133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous alternative veins may not provide better outcomes than prosthetic conduits for below-knee bypass when great saphenous vein is unavailable.
    Avgerinos ED; Sachdev U; Naddaf A; Doucet DR; Mohapatra A; Leers SA; Chaer RA; Makaroun MS
    J Vasc Surg; 2015 Aug; 62(2):385-91. PubMed ID: 25943451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloplastic bypass material below the knee: actual rationale.
    Debus ES; Larena-Avellaneda A; Heimlich F; Goertz J; Fein M
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):159-66. PubMed ID: 23443601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuncts to improve patency of infrainguinal prosthetic bypass grafts.
    Moawad J; Gagne P
    Vasc Endovascular Surg; 2003; 37(6):381-6. PubMed ID: 14671692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses.
    Dorigo W; Pulli R; Piffaretti G; Castelli P; Griselli F; Dorrucci V; Ferilli F; Ottavi P; De Blasis G; Scalisi L; Monaca V; Battaglia G; Vecchiati E; Casali G; Pratesi C
    J Cardiovasc Surg (Torino); 2012 Apr; 53(2):187-94. PubMed ID: 22456641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts.
    Ali AT; Modrall JG; Hocking J; Valentine RJ; Spencer H; Eidt JF; Clagett GP
    J Vasc Surg; 2009 Jul; 50(1):30-9. PubMed ID: 19563952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia.
    Neufang A; Espinola-Klein C; Dorweiler B; Savvidis S; Schmiedt W; Vahl CF
    Eur J Vasc Endovasc Surg; 2007 Nov; 34(5):583-9. PubMed ID: 17574877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.